Previous Close | 2.8000 |
Open | N/A |
Bid | 0.2000 |
Ask | 3.4000 |
Strike | 185.00 |
Expire Date | 2025-03-21 |
Day's Range | 2.8000 - 2.8000 |
Contract Range | N/A |
Volume | |
Open Interest | 2 |
Key Insights Becton Dickinson's estimated fair value is US$187 based on 2 Stage Free Cash Flow to Equity Becton...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits that will enable automation to ensure greater consistency and increased efficiency of large-scale, single-cell discovery studies.
Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.